+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Whooping Cough Pipeline Drugs and Companies, 2021- Phase, Mechanism of Action, Route, Licensing/Collaboration, Pre-clinical and Clinical Trials

  • PDF Icon


  • 70 Pages
  • November 2021
  • Region: Global
  • VPA Research
  • ID: 5463980
Whooping Cough pipeline drugs and companies, 2021- Phase, Mechanism of Action, Route, Licensing/collaboration, pre-clinical and clinical trials

The global comprehensive report on “Whooping Cough pipeline drugs and companies” presents key-decision makers with critical insights into Whooping Cough pipeline data. It provides complete analysis on pipeline drugs detailing Phases, route of administration, mechanism of action, licensing and collaborations, clinical trial details including pre-clinical phase and clinical trials.

Whooping Cough pipeline Drug Snapshot, 2021

The Whooping Cough pipeline study analyzes and monitors the development landscape with the current status of each of the pipeline drugs under development for Whooping Cough. In addition to recent status, overview of drugs is included in the study. Wide range of Whooping Cough drug related details including of company, indication, country, current status, drug alternative names, originator, orphan drug status, fast track details and others are provided.

Whooping Cough drug development pipeline by phase

The Whooping Cough pipeline study monitors the progress of new drug programs and provides analysis of phases, covering drugs from discovery to launch including discovery stage, preclinical, phase 1, phase 2, phase 3, pre-registration and other phases. The drug development stage for all Whooping Cough pipeline candidates is provided in the report enables you to understand timetable developments in Whooping Cough therapeutic area.

Whooping Cough pipeline drug Technology, Licensing and Collaboration Details

Details of technologies used for development of Whooping Cough pipeline candidates, licensing and collaboration agreements, partnership and other announcements, regulatory approval and other details are included in the Whooping Cough research study. Companies looking to partner with other players are also detailed in the report.

Whooping Cough- mechanism of action of pipeline candidates

Whooping Cough pipeline guide details the mechanism of action of each of the drug candidate under development. Further, leading types of mechanism of action (MoA) targeted by different Whooping Cough companies are identified to support decision makers target the most potential drugs under development.

Further, route of administration including oral, topical, sub-cutaneous, IV, ophthalmic and others are provided to assist researchers to understand most sought and least sought route of Whooping Cough drug administration.

Whooping Cough Drugs- Preclinical and Clinical Trials

This chapter in Whooping Cough preclinical and clinical trials assists in gaining clear understanding of the timetable developments in Whooping Cough product area. Preclinical and clinical trial details of pipeline candidates for Whooping Cough are detailed in the report. Details including participants, duration, companies, locations and others are provided for the trials.

Whooping Cough companies and Profiles

Companies developing Whooping Cough pipeline products are analyzed in the industry report, presenting details of business overview, location, and year of establishment, contacts, key employees, and a brief business profile.

Whooping Cough Market Developments

The report presents the recent news and developments in the Whooping Cough pipeline industry. Progress of candidates, mergers, acquisitions, asset transactions, licensing, collaborations, partnership and joint ventures, regulatory approvals, marketing and other relevant news and deals are discussed in the report.

Reasons to Buy

  • Make better-informed decisions based on the current status of each of the pipeline drug candidate
  • Identify new business opportunities by evaluating the progress of the Whooping Cough R&D pipeline
  • Analyze the market and research segments based on a comprehensive analysis of Whooping Cough pipeline drugs and clinical trials
  • Identify Whooping Cough drug pipeline trends based on consistently delivered hands on pipeline and clinical trials information
  • Gain clear understanding of the Whooping Cough drugs through our expert coverage and in-depth analysis of drugs, companies and market trends
  • Check the Whooping Cough pipeline progress of target companies and key strategies of leading players
  • Gain real-time insights into the global Whooping Cough pipeline news, developments and insights

Scope of the Report

  • Disease overview including Whooping Cough symptoms, widely used treatment options, companies and other details are included
  • Whooping Cough Pipeline Summary including the dominant phase type, number of drug candidates progressing to advanced phases, early stage pipeline candidates, leading companies, dominant route of mechanism and route of administration and other details are provided.
  • Whooping Cough pipeline drug count by phase, company and mechanism of action
  • Whooping Cough companies investing R&D resources in pipeline
  • Dominant Mechanism of Action
  • Most researched route of administration
  • For each pipeline candidate, drug, originator, co-developers, other companies, special status, phase, synonym, current status and other details are included
  • Clinical trial information for each Whooping Cough pipeline candidate are provided including preclinical, phase 1, phase 2 and phase 3 details
  • Whooping Cough companies including their business snapshot, business description and Whooping Cough pipelines are included.
  • Recent Whooping Cough market developments, pipeline news and deals are provided

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Executive Summary
2.1 Whooping Cough Disease overview
2.2 Companies investing in Whooping Cough industry
3 Whooping Cough Pipeline Snapshot, 2021
3.1 Whooping Cough Pipeline Drugs- Dominant phase type
3.2 Whooping Cough pipeline Drugs- Leading Mechanism of Action
3.3 Whooping Cough Pipeline Drugs- Widely researched Route of Administration
3.4 Whooping Cough Pipeline- New Molecular Entity
3.5 Whooping Cough pipeline- Companies, Universities and Institutes
4. Whooping Cough Drug Profiles
4.1 Current Status of Whooping Cough Drug Candidates, 2021
4.2 Whooping Cough Drugs in Development- Originator/Licensor
4.3 Whooping Cough Drugs in Development- Route of Administration
4.4 Whooping Cough Drugs in Development- New Molecular Entity (NME)
5. Whooping Cough Clinical Trials
5.1 Preclinical Trial details
5.2 Phase 1 Clinical Trial Details
5.3 Phase 2 Clinical Trial Details
5.4 Phase 3 Clinical Trial Details
6. Whooping Cough Companies and Universities
6.1 Leading Whooping Cough companies researching in drug development
6.2 Leading Whooping Cough Universities/Institutes investing in drug development
7. Whooping Cough News and Deals
7.1 Recent Whooping Cough Market Developments
7.2 Pipeline Drug News Updates
7.3 Pipeline Company updates
8. Appendix
8.1 Sources and Research Methodology
8.2 Online Database
8.3 Primary and Secondary Methodology
8.4 Customization options
8.5 Contact